The Oncology Institute, Inc. TOI Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s convertible preferred stock outstanding shares.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s convertible preferred stock outstanding shares?
- The Oncology Institute, Inc. (TOI) reported convertible preferred stock outstanding shares of 193.5K in Q1 2026.
- How has The Oncology Institute, Inc.'s convertible preferred stock outstanding shares changed year-over-year?
- The Oncology Institute, Inc.'s convertible preferred stock outstanding shares decreased by 4.3% year-over-year, from 202.3K to 193.5K.
- What is the long-term trend for The Oncology Institute, Inc.'s convertible preferred stock outstanding shares?
- Over 4 years (2021 to 2025), The Oncology Institute, Inc.'s convertible preferred stock outstanding shares has grown at a 4.3% compound annual growth rate (CAGR), from 163.5K to 193.5K.